|
Market Closed -
Bombay S.E.
03:32:30 01/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,632.35 INR | -2.82% |
|
-7.17% | +42.97% |
| 25/09 | Caplin Point Laboratories Limited Approves Appointment of D Muralidharan as Whole Time Director | CI |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPLIN POINT LABORATORIES LIMITED | Generic Pharmaceuticals | -2.82% | -7.17% | +42.97% | +27.99% | +200.41% | 207.82Cr |  | | |
- Stock Market
- Stocks
- 524742 Stock
- Charts Caplin Point Laboratories Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
